BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9066718)

  • 1. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen.
    So FV; Guthrie N; Chambers AF; Carroll KK
    Cancer Lett; 1997 Jan; 112(2):127-33. PubMed ID: 9066718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
    Zava DT; Duwe G
    Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer.
    Caltagirone S; Ranelletti FO; Rinelli A; Maggiano N; Colasante A; Musiani P; Aiello FB; Piantelli M
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):51-9. PubMed ID: 9224209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells.
    Po LS; Chen ZY; Tsang DS; Leung LK
    Cancer Lett; 2002 Dec; 187(1-2):33-40. PubMed ID: 12359348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
    Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
    Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids.
    Le Bail JC; Varnat F; Nicolas JC; Habrioux G
    Cancer Lett; 1998 Aug; 130(1-2):209-16. PubMed ID: 9751276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoid effects relevant to cancer.
    Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
    J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
    LaVallee TM; Zhan XH; Herbstritt CJ; Kough EC; Green SJ; Pribluda VS
    Cancer Res; 2002 Jul; 62(13):3691-7. PubMed ID: 12097276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA; Thompson LU
    Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene.
    Peterson G; Barnes S
    Biochem Biophys Res Commun; 1991 Aug; 179(1):661-7. PubMed ID: 1883387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro.
    Fioravanti L; Cappelletti V; Miodini P; Ronchi E; Brivio M; Di Fronzo G
    Cancer Lett; 1998 Aug; 130(1-2):143-52. PubMed ID: 9751267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular effects of genistein on estrogen receptor mediated pathways.
    Wang TT; Sathyamoorthy N; Phang JM
    Carcinogenesis; 1996 Feb; 17(2):271-5. PubMed ID: 8625449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibitory effects of flavonoids in human thyroid cancer cell lines.
    Yin F; Giuliano AE; Van Herle AJ
    Thyroid; 1999 Apr; 9(4):369-76. PubMed ID: 10319943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytoestrogen interaction with estrogen receptors in human breast cancer cells.
    Martin PM; Horwitz KB; Ryan DS; McGuire WL
    Endocrinology; 1978 Nov; 103(5):1860-7. PubMed ID: 570914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
    He FJ; Wang J; Niu JZ; Wang JF
    Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids.
    Han DH; Denison MS; Tachibana H; Yamada K
    Biosci Biotechnol Biochem; 2002 Jul; 66(7):1479-87. PubMed ID: 12224631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells.
    Peterson G; Barnes S
    Cell Growth Differ; 1996 Oct; 7(10):1345-51. PubMed ID: 8891338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
    Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK
    Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.